Overview Dividends

(LRCX) Lam Research - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5128073062

Deposition,Etch,Clean,Refurbish,Service

LRCX EPS (Earnings per Share)

EPS Growth (3Y CAGR): -52.70%
EPS Trend (3Y Correlation): -82.4%

LRCX Revenue

Revenue Growth (3Y CAGR): 0.69%
Revenue Trend (3Y Correlation): 13.2%

Description: LRCX Lam Research

Lam Research Corp (NASDAQ:LRCX) designs, manufactures, markets, refurbishes, and services a full suite of semiconductor processing tools used to build integrated circuits worldwide. Its portfolio spans deposition (ALTUS, SABRE, SPEED, Striker, VECTOR), etch (Flex, Vantex, Kiyo, Syndion, Versys), cleaning (Coronus, Da Vinci, DV-Prime, EOS, SP series) and advanced platform solutions (Reliant, Sense.i), supported by service, spares, and upgrades.

Key quantitative signals (FY 2023): revenue of $17.6 billion, up ~13 % YoY, driven by strong demand for advanced-node equipment (3 nm and below) and growth in AI-related workloads. The company’s gross margin held at ~46 %, reflecting pricing power in a concentrated market where Lam commands ~30 % share of the global wafer-fab equipment spend. Capital-expenditure cycles in the semiconductor sector, amplified by the U.S. CHIPS Act and rising fab capacity in Taiwan, South Korea, and the U.S., remain the primary macro driver of Lam’s order backlog.

For a deeper, data-rich evaluation of Lam’s valuation dynamics, you may find ValueRay’s analyst toolkit useful for extending this initial overview.

LRCX Stock Overview

Market Cap in USD	179,533m
Sub-Industry	Semiconductor Materials & Equipment
IPO / Inception	1984-05-11

LRCX Stock Ratings

Growth Rating	88.7%
Fundamental	79.9%
Dividend Rating	68.6%
Return 12m vs S&P 500	71.7%
Analyst Rating	4.33 of 5

LRCX Dividends

Dividend Yield 12m	0.66%
Yield on Cost 5y	2.80%
Annual Growth 5y	15.10%
Payout Consistency	100.0%
Payout Ratio	23.0%

LRCX Growth Ratios

Growth Correlation 3m	90.9%
Growth Correlation 12m	79.6%
Growth Correlation 5y	74.3%
CAGR 5y	59.20%
CAGR/Max DD 3y (Calmar Ratio)	1.26
CAGR/Mean DD 3y (Pain Ratio)	4.45
Sharpe Ratio 12m	1.21
Alpha	69.16
Beta	1.841
Volatility	49.00%
Current Volume	8919.4k
Average Volume 20d	11015.5k
Stop Loss	135.2 (-6.1%)
Signal	-0.05

Piotroski VR‑10 (Strict, 0-10) 9.0

Net Income (5.36b TTM) > 0 and > 6% of Revenue (6% = 1.11b TTM)

FCFTA 0.27 (>2.0%) and ΔFCFTA 4.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 43.12% (prev 57.33%; Δ -14.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.29 (>3.0%) and CFO 6.17b > Net Income 5.36b (YES >=105%, WARN >=100%)

Net Debt (-1.91b) to EBITDA (6.48b) ratio: -0.29 <= 3.0 (WARN <= 3.5)

Current Ratio 2.21 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (1.28b) change vs 12m ago -2.61% (target <= -2.0% for YES)

Gross Margin 48.71% (prev 47.32%; Δ 1.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 91.97% (prev 79.52%; Δ 12.45pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 34.19 (EBITDA TTM 6.48b / Interest Expense TTM 178.2m) >= 6 (WARN >= 3)

Altman Z'' 11.56

(A) 0.37 = (Total Current Assets 14.52b - Total Current Liabilities 6.57b) / Total Assets 21.35b

(B) 1.36 = Retained Earnings (Balance) 28.99b / Total Assets 21.35b

warn (B) unusual magnitude: 1.36 — check mapping/units

(D) 2.52 = Book Value of Equity 28.93b / Total Liabilities 11.48b

Total Rating: 11.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.88

1. Piotroski 9.0pt = 4.0

2. FCF Yield 3.22% = 1.61

3. FCF Margin 30.99% = 7.50

4. Debt/Equity 0.45 = 2.40

5. Debt/Ebitda -0.29 = 2.50

6. ROIC - WACC (= 29.90)% = 12.50

7. RoE 58.48% = 2.50

8. Rev. Trend 13.22% = 0.99

9. EPS Trend -82.38% = -4.12

What is the price of LRCX shares?

As of October 21, 2025, the stock is trading at USD 144.05 with a total of 8,919,374 shares traded.
Over the past week, the price has changed by +4.53%, over one month by +9.18%, over three months by +41.87% and over the past year by +99.86%.

Is Lam Research a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Lam Research (NASDAQ:LRCX) is currently (October 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 79.88 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LRCX is around 189.15 USD . This means that LRCX is currently undervalued and has a potential upside of +31.31% (Margin of Safety).

Is LRCX a buy, sell or hold?

Lam Research has received a consensus analysts rating of 4.33. Therefore, it is recommended to buy LRCX.

Strong Buy: 20
Buy: 4
Hold: 9
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the LRCX price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	128.2	-11%
Analysts Target Price	128.2	-11%
ValueRay Target Price	218.5	51.7%

Last update: 2025-10-18 05:03

LRCX Fundamental Data Overview

Market Cap USD = 179.53b (179.53b USD * 1.0 USD.USD)
P/E Trailing = 34.3889
P/E Forward = 32.8947
P/S = 9.7384
P/B = 18.796
P/EG = 2.3915
Beta = 1.841
Revenue TTM = 18.44b USD
EBIT TTM = 6.09b USD
EBITDA TTM = 6.48b USD
Long Term Debt = 3.72b USD (from longTermDebt, last quarter)
Short Term Debt = 754.3m USD (from shortTermDebt, last quarter)
Debt = 4.48b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.91b USD (from netDebt column, last quarter)
Enterprise Value = 177.63b USD (179.53b + Debt 4.48b - CCE 6.39b)
Interest Coverage Ratio = 34.19 (Ebit TTM 6.09b / Interest Expense TTM 178.2m)
FCF Yield = 3.22% (FCF TTM 5.71b / Enterprise Value 177.63b)
FCF Margin = 30.99% (FCF TTM 5.71b / Revenue TTM 18.44b)
Net Margin = 29.06% (Net Income TTM 5.36b / Revenue TTM 18.44b)
Gross Margin = 48.71% ((Revenue TTM 18.44b - Cost of Revenue TTM 9.46b) / Revenue TTM)
Gross Margin QoQ = 50.08% (prev 49.02%)
Tobins Q-Ratio = 8.32 (Enterprise Value 177.63b / Total Assets 21.35b)
Interest Expense / Debt = 0.95% (Interest Expense 42.8m / Debt 4.48b)
Taxrate = 3.31% (58.9m / 1.78b)
NOPAT = 5.89b (EBIT 6.09b * (1 - 3.31%))
Current Ratio = 2.21 (Total Current Assets 14.52b / Total Current Liabilities 6.57b)
Debt / Equity = 0.45 (Debt 4.48b / totalStockholderEquity, last quarter 9.86b)
Debt / EBITDA = -0.29 (Net Debt -1.91b / EBITDA 6.48b)
Debt / FCF = -0.33 (Net Debt -1.91b / FCF TTM 5.71b)
Total Stockholder Equity = 9.16b (last 4 quarters mean from totalStockholderEquity)
RoA = 25.10% (Net Income 5.36b / Total Assets 21.35b)
RoE = 58.48% (Net Income TTM 5.36b / Total Stockholder Equity 9.16b)
RoCE = 47.30% (EBIT 6.09b / Capital Employed (Equity 9.16b + L.T.Debt 3.72b))
RoIC = 42.41% (NOPAT 5.89b / Invested Capital 13.89b)
WACC = 12.51% (E(179.53b)/V(184.02b) * Re(12.80%) + D(4.48b)/V(184.02b) * Rd(0.95%) * (1-Tc(0.03)))
Discount Rate = 12.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.73%
[DCF Debug] Terminal Value 64.65% ; FCFE base≈5.13b ; Y1≈5.60b ; Y5≈7.08b
Fair Price DCF = 49.99 (DCF Value 63.04b / Shares Outstanding 1.26b; 5y FCF grow 10.45% → 3.0% )
EPS Correlation: -82.38 | EPS CAGR: -52.70% | SUE: 0.36 | # QB: 0
Revenue Correlation: 13.22 | Revenue CAGR: 0.69% | SUE: 4.0 | # QB: 4

Additional Sources for LRCX Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle